Lamivudine for system suitability 2
SIAL/Y0000426 - European Pharmacopoeia (EP) Reference Standard
Synonym: Lamivudine; 2′,3′-Dideoxy-3′-thiacytidine; 3TC; Epivir; Epivir-HBV; Heptovir; Zeffix
CAS Number: 134678-17-4
Empirical Formula (Hill Notation): C8H11N3O3S
Molecular Weight: 229.26
MDL Number: MFCD00869739
Linear Formula: C8H11N3O3S
Product Type: Chemical
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C8H11N3O3S/c9-5-1-2-11 |
InChI key | JTEGQNOMFQHVDC-NKWVEPMBSA |
manufacturer/tradename | EDQM |
SMILES string | NC1=NC(=O)N(C=C1)[C@@H]2C |
storage temp. | 2-8°C |
Biochem/physiol Actions: | Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor (nRTI). It is an analogue of cytidine, and can inhibit both types (1 and 2) of HIV reverse transcriptase as well as the reverse transcriptase of hepatitis B. It needs to be phosphorylated to its triphosphate form before it is active. 3TC-triphosphate also inhibits cellular DNA polymerase. |
Caution: | Please find SDS provided by EDQM here. ![]() ![]() |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia ![]() ![]() |
Other Notes: | Sales restrictions may apply. |
Packaging: | Unit quantity: 10.3 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue ![]() ![]() |
Symbol | ![]() |
Signal word | Warning |
Hazard statements | H361 |
Precautionary statements | P280 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 41116107 |